Month: July 2021

SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing...

MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings call at 8:00 a.m. ET. Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00...

SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 12:00 pm ET. To access the live webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Chinook’s website. The archived webcast will remain available for replay on Chinook’s website for 30 days. About Chinook Therapeutics, Inc.Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinook’s product candidates...

B. Riley Executive Brings Strong Financial Acumen to the Board BRIDGEWATER, N.J., July 12, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital solutions, is pleased to announce that Martin Bernstein has joined its Board of Directors, effective immediately. Bernstein was appointed to the Board in connection with the recent recapitalization of Synchronoss, and serves as a representative of B. Riley Financial, Inc. (NASDAQ: RILY) (B. Riley), the company’s largest shareholder. “On behalf of our entire Board, I am pleased to welcome Marty to our team,” said Stephen Waldis, Founder and Executive Chairman of the Synchronoss Board of Directors. “Marty’s extensive experience in capital allocation strategies, corporate governance and financing will serve our...

Company to highlight its latest product verbMAIL, an interactive video sales technology that integrates with Microsoft Outlook NEWPORT BEACH, Calif. and SALT LAKE CITY, July 12, 2021 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (NASDAQ: VERB) (“VERB” or the “Company”), a leader in interactive video-based sales enablement applications, including interactive livestream eCommerce, webinar, CRM and marketing applications for entrepreneurs and enterprises, today announced that CEO Rory J. Cutaia will present virtually at the Issuer Direct’s Access to Giving Virtual Investor Conference to be held July 13-15, 2021. Mr. Cutaia will provide a Company overview which includes its suite of products: verbCRM, verbLIVE, verbTEAMS, verbLEARN, as well as the recently launched, verbMAIL, its latest interactive...

QUEBEC CITY, July 12, 2021 (GLOBE NEWSWIRE) — ORLETTO CAPITAL II INC. (TSX-V “OLT.P”) (the “Corporation”) is pleased to announce that all matters submitted to its shareholders for approval as set out in detail in the Corporation’s management information circular dated May 25, 2021 (the “Circular”) were approved at the annual general and special meeting of the shareholders of the Corporation held on June 22, 2021 (the “Meeting”). At the Meeting, the incumbent members of the board of directors, being Benoit Chotard, Octavio Soares, Claude Pouliot and Cynthia Mailloux, were elected as directors, Mallette LLP was re-appointed as the auditor of the Corporation, and the Corporation’s proposed stock option plan was approved and confirmed, conditional to the completion of a qualifying transaction. Moreover, the shareholders of the Corporation...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., July 12, 2021 (GLOBE NEWSWIRE) — Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” or the “Company”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement (the “Offering”) of 1,390,000 common shares (“Common Shares”) of the Company to raise approximately CAN$375,000 at a price of CAN$0.27 per Common Share. Avisa intends to use the net proceeds from the Offering for operations and expansion of its business and for general working capital purposes. The Offering is expected to close on or about July 15, 2021, subject to satisfaction...

NEW YORK, July 12, 2021 (GLOBE NEWSWIRE) — Katapult will release its second quarter ended June 30, 2021 financial results on Tuesday, August 10, 2021, before market open. The company will host a conference call and webcast at 8:00 AM ET on Tuesday, August 10, 2021 to discuss the company’s financial results. A live audio webcast of the event will be available on the Katapult Investor Relations website at http://ir.katapultholdings.com/. A live dial-in will be available at (888) 302-0680 (domestic) or (281) 962-4859 (international). The conference ID number is 1768299. Shortly after the conclusion of the call, a replay of this conference call will be available through 11:00 AM ET on August 24, 2021 at (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay passcode is 1768299. Contacts Investor Inquiries:Katapult...

New program designed to help fill growing demand for automotive technicians Parsippany, NJ, July 12, 2021 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), marking 75 years in 2021 as a national leader in specialized technical training, will introduce Mazda Automotive Student Training (MAST) at its Columbia, MD campus this summer. Students enrolled in Automotive Technology training can add the Mazda option to their program and build career skills specific to Mazda technologies.   Mazda Automotive Student Training (MAST) may include a number of  benefits* for accepted students, such as career placement opportunities with a living wage at participating local Mazda dealerships, one-on-one mentorships with Mazda Master or Senior Certified Techs, discounts on tool kits and Mazda vehicles, and up to $15,000...